The role of reverse genetics systems in studying viral hemorrhagic fevers

Hideki Ebihara, Allison Groseth, Gabriele Neumann, Yoshihiro Kawaoka, Heinz Feldmann

Research output: Contribution to journalReview article

16 Citations (Scopus)

Abstract

Viral hemorrhagic fever (VHF) is an infectious syndrome in humans often associated with high fatality rates. For most VHFs there are no specific and effective therapies or vaccines available and, in general, there is a lack of knowledge regarding the biology and pathogenesis of the causative agents. Therefore, a more detailed understanding of the molecular basis of VHF pathogenesis, including the identification of viral virulence determinants and host interactions and responses, will be important to enhance our ability to control VHF infections. The recently developed "reverse genetics systems" for several VHF causing viruses have allowed the generation of infectious viruses from cloned cDNA and thus, the generation of virus mutants. Here we review the existing reverse genetics systems for VHF causing viruses and discuss their use in studying viral replication, pathogenesis, and the development of antivirals and vaccines.

Original languageEnglish (US)
Pages (from-to)240-253
Number of pages14
JournalThrombosis and Haemostasis
Volume94
Issue number2
DOIs
StatePublished - Aug 1 2005
Externally publishedYes

Fingerprint

Viral Hemorrhagic Fevers
Reverse Genetics
Viruses
Active Immunotherapy
Antiviral Agents
Virulence
Vaccines
Complementary DNA
Infection

Keywords

  • Pathogenesis
  • Reverse genetic systems
  • Viral hemorrhagic fever

ASJC Scopus subject areas

  • Hematology

Cite this

The role of reverse genetics systems in studying viral hemorrhagic fevers. / Ebihara, Hideki; Groseth, Allison; Neumann, Gabriele; Kawaoka, Yoshihiro; Feldmann, Heinz.

In: Thrombosis and Haemostasis, Vol. 94, No. 2, 01.08.2005, p. 240-253.

Research output: Contribution to journalReview article

Ebihara, Hideki ; Groseth, Allison ; Neumann, Gabriele ; Kawaoka, Yoshihiro ; Feldmann, Heinz. / The role of reverse genetics systems in studying viral hemorrhagic fevers. In: Thrombosis and Haemostasis. 2005 ; Vol. 94, No. 2. pp. 240-253.
@article{177ec38eada84c548ac300c0ffb61c50,
title = "The role of reverse genetics systems in studying viral hemorrhagic fevers",
abstract = "Viral hemorrhagic fever (VHF) is an infectious syndrome in humans often associated with high fatality rates. For most VHFs there are no specific and effective therapies or vaccines available and, in general, there is a lack of knowledge regarding the biology and pathogenesis of the causative agents. Therefore, a more detailed understanding of the molecular basis of VHF pathogenesis, including the identification of viral virulence determinants and host interactions and responses, will be important to enhance our ability to control VHF infections. The recently developed {"}reverse genetics systems{"} for several VHF causing viruses have allowed the generation of infectious viruses from cloned cDNA and thus, the generation of virus mutants. Here we review the existing reverse genetics systems for VHF causing viruses and discuss their use in studying viral replication, pathogenesis, and the development of antivirals and vaccines.",
keywords = "Pathogenesis, Reverse genetic systems, Viral hemorrhagic fever",
author = "Hideki Ebihara and Allison Groseth and Gabriele Neumann and Yoshihiro Kawaoka and Heinz Feldmann",
year = "2005",
month = "8",
day = "1",
doi = "10.1160/TH05-05-0335",
language = "English (US)",
volume = "94",
pages = "240--253",
journal = "Thrombosis and Haemostasis",
issn = "0340-6245",
publisher = "Schattauer GmbH",
number = "2",

}

TY - JOUR

T1 - The role of reverse genetics systems in studying viral hemorrhagic fevers

AU - Ebihara, Hideki

AU - Groseth, Allison

AU - Neumann, Gabriele

AU - Kawaoka, Yoshihiro

AU - Feldmann, Heinz

PY - 2005/8/1

Y1 - 2005/8/1

N2 - Viral hemorrhagic fever (VHF) is an infectious syndrome in humans often associated with high fatality rates. For most VHFs there are no specific and effective therapies or vaccines available and, in general, there is a lack of knowledge regarding the biology and pathogenesis of the causative agents. Therefore, a more detailed understanding of the molecular basis of VHF pathogenesis, including the identification of viral virulence determinants and host interactions and responses, will be important to enhance our ability to control VHF infections. The recently developed "reverse genetics systems" for several VHF causing viruses have allowed the generation of infectious viruses from cloned cDNA and thus, the generation of virus mutants. Here we review the existing reverse genetics systems for VHF causing viruses and discuss their use in studying viral replication, pathogenesis, and the development of antivirals and vaccines.

AB - Viral hemorrhagic fever (VHF) is an infectious syndrome in humans often associated with high fatality rates. For most VHFs there are no specific and effective therapies or vaccines available and, in general, there is a lack of knowledge regarding the biology and pathogenesis of the causative agents. Therefore, a more detailed understanding of the molecular basis of VHF pathogenesis, including the identification of viral virulence determinants and host interactions and responses, will be important to enhance our ability to control VHF infections. The recently developed "reverse genetics systems" for several VHF causing viruses have allowed the generation of infectious viruses from cloned cDNA and thus, the generation of virus mutants. Here we review the existing reverse genetics systems for VHF causing viruses and discuss their use in studying viral replication, pathogenesis, and the development of antivirals and vaccines.

KW - Pathogenesis

KW - Reverse genetic systems

KW - Viral hemorrhagic fever

UR - http://www.scopus.com/inward/record.url?scp=23744512867&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23744512867&partnerID=8YFLogxK

U2 - 10.1160/TH05-05-0335

DO - 10.1160/TH05-05-0335

M3 - Review article

VL - 94

SP - 240

EP - 253

JO - Thrombosis and Haemostasis

JF - Thrombosis and Haemostasis

SN - 0340-6245

IS - 2

ER -